Peer-reviewedCC BYFrontiers in immunology
Immune checkpoint inhibitors and the inflammatory dysregulation: decoding cutaneous and gastrointestinal immune-related adverse events for the allergist and immunologist
- 1Maternal and Children’s Health Research Institute, Shunde Women and Children’s Hospital, Guangdong Medical University , ,
- 2Department of Pediatrics, Shunde Women and Children Hospital, Guangdong Medical University , ,
Related
- Commentary: Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management
- 454 Second primary hematologic malignancies in melanoma survivors before and after the introduction of immune checkpoint inhibitors: a population-based SEER analysis
- Comparative efficacy and safety of low dose vs. standard-dose immune checkpoint inhibitors: A systematic review and meta-analysis
- Comparative profiling of MAIT cells across gastrointestinal cancers identifies conserved NK receptor dysregulation and HCC-specific defects in cytotoxicity and XBP1s signaling
- Fluoropyrimidine-associated gastrointestinal toxicity: pharmacovigilance reporting signals and in vitro evidence of epithelial injury, barrier impairment, and inflammatory responses
BibTeX
@article{wasim2026immune,
title = {{Immune checkpoint inhibitors and the inflammatory dysregulation: decoding cutaneous and gastrointestinal immune-related adverse events for the allergist and immunologist}},
author = {Muhammad Wasim and Guoda Ma and Yajun Wang},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13659581},
note = {CC BY},
}
RIS
TY - JOUR
TI - Immune checkpoint inhibitors and the inflammatory dysregulation: decoding cutaneous and gastrointestinal immune-related adverse events for the allergist and immunologist
AU - Muhammad Wasim
AU - Guoda Ma
AU - Yajun Wang
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13659581
SN - 1664-3224
ER -